新型コロナウイルス感染症診断の世界市場2020-2027:製品別、サンプルタイプ別、技術別、最終用途別

◆英語タイトル:COVID-19 Diagnostics Market Size, Share & Trends Analysis Report By Product, By Sample Type (Oropharyngeal & Nasopharyngeal Swabs, Blood, Urine), By Technology (PCR, ELISA, POC), By End Use, And Segment Forecasts, 2020 - 2027
◆商品コード:GV20JN079
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年5月
◆ページ数:150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後2週間)
◆調査対象地域:クローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥618,800見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥722,800見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥930,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、新型コロナウイルス感染症診断の世界市場を調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場の要因・動向・範囲、製品別(機器、試薬・キット)分析、サンプルタイプ別分析、技術別分析、最終用途別分析、地域別分析、競争状況など、今後の市場展望をまとめております。
・調査手法・範囲
・エグゼクティブサマリー
・市場の要因・動向・範囲
・新型コロナウイルス感染症診断の世界市場規模:製品別(機器、試薬・キット)
・新型コロナウイルス感染症診断の世界市場規模:サンプルタイプ別
・新型コロナウイルス感染症診断の世界市場規模:技術別
・新型コロナウイルス感染症診断の世界市場規模:最終用途別
・新型コロナウイルス感染症診断の世界市場規模:地域別
・競争状況
【レポートの概要】

COVID-19 Diagnostics Market Growth & Trends

The global COVID-19 diagnostics market size is expected to reach USD 7.8 billion by 2027, registering a CAGR of 5.96% during the forecast period, according to a new report by Grand View Research, Inc. Increase in need for mass testing and efficiency in infection diagnosis are key contributors for the market growth. COVID-19 mass testing has been largely favored by European countries, which is a primary factor that can be attributed to the dominance of this region in the global market.

Large-scale operational entities in Sweden, such as Tele2, H&M, and Spotify are engaged in mass testing for distinguishing the staff who were tested positive from those not affected by the infection. The clothing company H&M arranged for mass testing of more than 4,000 employees. In addition, virologists have stated that the relatively low-death rates associated with coronavirus in Germany can be attributed to early implementation of mass testing in the country. This is further propelled by robust strategies devised by authorities to contain the spread of coronavirus in the country; in March 2020, Germany carried out mass testing reaching an average of 500,000 people every week.

Exploring the potential of novel molecular technologies in the scaling-up of coronavirus testing is expected to offer a significant momentum to the expansion of the market for COVID-19 diagnostics. For instance, CRISPR-a gene editing technology-has recently made its way into the coronavirus testing market. This gene editing technology enables detection of SARS-CoV-2 genes, via a protein, namely, CRISPR-Cas12. Acknowledging the potential of this technology in diagnosing coronavirus patients, the Food and Drug Administration (FDA) recently approved CRISPR test for coronavirus patients in U.S. This diagnostic kit has been approved under the provisions of emergency use.

Expanding pool of startup companies actively operating in the market is also expected to intensify market participant competition. This trend has been prominently observed in Asia Pacific, contributing to the fast-paced growth expected to be witnessed through 2021 to 2027. Some of the startup manufacturers of novel COVID-19 tests include Mylab, DNA Xperts Private Limited, Rokid, Bione, and SD Biosensor, among others.

COVID-19 Diagnostics Market Report Highlights

• Oropharyngeal and nasopharyngeal swabs are estimated to dominate the market in 2020 estimated to account for a share of 53% and this sample type is anticipated to maintain its dominance through 2021 to 2027

• Nasopharyngeal swabs are the gold standard for COVID-19 sample collection; both oropharyngeal and nasopharyngeal swabs are largely employed in PCR testing

• Increasing popularity of at-home testing and handheld instruments targeted toward combating shortage of coronavirus test kits has been witnessed. This has propelled the expansion of point-of-care COVID-19 testing market space, which has contributed to the segment’s fast-paced growth through 2021 to 2027

• Europe is estimated to dominate the market in 2020 estimated to account for a revenue share of 40% and is expected to maintain this dominance through 2020 to 2027. This is attributed to the robust funding for fast-track studies pertaining to clinical validation of rapid tests for COVID-19, by the European Commission and Member States

• Robust government initiatives aimed at increasing the number of operational laboratories dedicated to coronavirus testing, especially across Asia Pacific is set to propel the growth

【レポートの目次】

Table of Contents

Chapter 1 COVID-19 Diagnostics Market: Methodology and Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates and forecast timeline
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’S internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume price analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Objectives
1.9.1 Objective 1:
1.9.2 Objective 2:
Chapter 2 COVID-19 Diagnostics Market: Executive Summary
2.1 COVID-19 Diagnostics Market: Market Outlook
2.2 COVID-19 Diagnostics Market: Market Segmentation
2.3 COVID-19 Diagnostics Market: Competitive Insights
2.4 Market Summary
Chapter 3 COVID-19 Diagnostics Market: Market Variables, Trends & Scope
3.1 COVID-19 Diagnostics Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration & Growth Prospect Mapping for Technology, 2020
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Increase in the incidence of coronavirus globally
3.3.1.1.1 North America
3.3.1.1.2 Europe
3.3.1.1.3 Asia Pacific
3.3.1.1.4 Latin America
3.3.1.1.5 Middle East and Africa
3.3.1.2 Rise in product approvals by regulatory agencies
3.3.1.3 Funding and investments initiated for the expansion of COVID-19 diagnosis
3.3.1.4 Paradigm shift towards Point-of-Care (POC) testing
3.3.2 Market restraint analysis
3.3.2.1 Limited testing capacity
3.3.2.2 Lack of awareness related to coronavirus symptoms and testing
3.3.3 Market opportunity analysis
3.3.3.1 Increasing popularity of telehealth in the diagnosis of coronavirus
3.3.3.2 Favorable reimbursement scenario
3.3.4 Market challenge analysis
3.3.4.1 Challenges pertaining to coronavirus testing in healthcare settings
3.4 Business environment analysis
3.4.1 COVID-19 diagnostics market: SWOT analysis; by factor (political & legal, economic and technological)
3.4.2 Porter’s five forces analysis
3.5 COVID-19 Diagnostics: Company Position Analysis
3.6 COVID-19 Diagnostics: Healthcare Spending and Funding Scenario in Different Countries
3.6.1 U.S.
3.6.2 China
3.6.3 Italy
3.6.4 Germany
3.6.5 Japan
3.6.6 Others
3.7 Regulatory Guidelines for COVID-19 Diagnostic Testing
3.8 Effect on Swabs Market
3.8.1 Production shortage for viral transport media
3.8.2 Companies leading the viral transport media market
3.8.2.1 COPAN Diagnostics
3.8.2.2 Puritan Medical Products
3.8.2.3 Thermo Fisher Scientific
3.8.2.4 Becton, Dickinson and Company
3.8.2.5 Other emerging companies
Chapter 4 COVID-19 Diagnostics Market: Product Business Analysis
4.1 COVID-19 Diagnostics Market: Products Movement Analysis
4.2 Instruments
4.2.1 Global COVID-19 diagnostics instruments market, 2020 – 2027 (USD Million)
4.3 Reagents & Kits
4.3.1 Global COVID-19 reagents & kits market, 2020 – 2027 (USD Million)
Chapter 5 COVID-19 Diagnostics Market: Sample Type Business Analysis
5.1 COVID-19 Diagnostics Market: Sample Type Movement Analysis
5.2 Oropharyngeal & Nasopharyngeal Swabs
5.2.1 COVID-19 diagnostics market by oropharyngeal & nasopharyngeal swabs, 2020 – 2027 (USD Million)
5.3 Blood
5.3.1 COVID-19 diagnostics market by blood samples, 2020 – 2027 (USD Million)
5.4 Urine
5.4.1 COVID-19 diagnostics market by urine samples, 2020 – 2027 (USD Million)
5.5 Others
5.5.1 GLOBAL COVID-19 diagnostics market by other samples, 2020 – 2027 (USD Million)
Chapter 6 COVID-19 Diagnostics Market: Technology Business Analysis
6.1 COVID-19 Diagnostics Market: Technology Movement Analysis
6.2 Polymerase Chain Reaction (PCR)
6.2.1 COVID-19 diagnostics market by PCR, 2020 – 2027 (USD Million)
6.3 Antibody or Enzyme-Linked Immunosorbent Assay (ELISA)
6.3.1 COVID-19 DIAGNOSTICS market by antibody or enzyme-linked immunosorbent assay (ELISA), 2020 – 2027 (USD Million)
6.4 Serology
6.4.1 COVID-19 diagnostics market by serology, 2020 – 2027 (USD Million)
6.5 Portable or Point-of-Care
6.5.1 COVID-19 diagnostics market by portable or point-of-care, 2020 – 2027 (USD Million)
6.6 Other Technologies
6.6.1 COVID-19 diagnostics market by other technologies, 2020 – 2027 (USD Million)
Chapter 7 COVID-19 Diagnostics Market: End-use Business Analysis
7.1 COVID-19 Diagnostics Market: End-use Movement Analysis
7.2 Laboratories
7.2.1 COVID-19 diagnostics market in laboratories, 2020 – 2027 (USD Million)
7.3 Hospitals
7.3.1 COVID-19 diagnostics market in hospitals, 2020 – 2027 (USD Million)
7.4 Diagnostic Centers and Clinics
7.4.1 COVID-19 diagnostics market in diagnostic centers and clinics, 2020 – 2027 (USD Million)
7.5 Research Institutes
7.5.1 COVID-19 diagnostics market in research institutes, 2020 – 2027 (USD Million)
Chapter 8 COVID-19 Diagnostics Market: Regional Business Analysis
8.1 COVID-19 Diagnostics Market: Regional Movement Analysis, 2020 & 2027
8.2 North America
8.2.1 North America COVID-19 diagnostics market estimates and forecast, 2020 – 2027 (USD Million)
8.2.2 U.S.
8.2.2.1 COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
8.2.2.2 COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
8.2.2.3 COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
8.2.2.4 COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
8.2.3
8.2.3.1 COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
8.2.3.2 COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
8.2.3.3 COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
8.2.3.4 COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
8.3 Europe
8.3.1 Europe COVID-19 diagnostics market estimates and forecast, 2020 – 2027 (USD Million)
8.3.2 Germany
8.3.2.1 COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
8.3.2.2 COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
8.3.2.3 COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
8.3.2.4 COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
8.3.3 U.K.
8.3.3.1 COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
8.3.3.2 COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
8.3.3.3 COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
8.3.3.4 COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
8.3.4 France
8.3.4.1 COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
8.3.4.2 COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
8.3.4.3 COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
8.3.4.4 COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
8.3.5 Italy
8.3.5.1 COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
8.3.5.2 COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
8.3.5.3 COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
8.3.5.4 COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
8.3.6 Spain
8.3.6.1 COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
8.3.6.2 COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
8.3.6.3 COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
8.3.6.4 COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
8.4 Asia-Pacific
8.4.1 Asia Pacific COVID-19 diagnostics market estimates and forecast, 2020 – 2027 (USD Million)
8.4.2 China
8.4.2.1 COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
8.4.2.2 COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
8.4.2.3 COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
8.4.2.4 COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
8.4.3 India
8.4.3.1 COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
8.4.3.2 COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
8.4.3.3 COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
8.4.3.4 COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
8.4.4 Japan
8.4.4.1 COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
8.4.4.2 COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
8.4.4.3 COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
8.4.4.4 COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
8.4.5 South Korea
8.4.5.1 COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
8.4.5.2 COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
8.4.5.3 COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
8.4.5.4 COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
8.4.6 Australia
8.4.6.1 COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
8.4.6.2 COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
8.4.6.3 COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
8.4.6.4 COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
8.5 Latin America
8.5.1 Latin America COVID-19 diagnostics market estimates and forecast, 2020 – 2027 (USD Million)
8.5.2 Brazil
8.5.2.1 COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
8.5.2.2 COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
8.5.2.3 COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
8.5.2.4 COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
8.5.3 Mexico
8.5.3.1 COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
8.5.3.2 COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
8.5.3.3 COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
8.5.3.4 COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
8.6 Middle East and Africa (MEA)
8.6.1 MEA COVID-19 diagnostics market estimates and forecast, 2020 – 2027 (USD Million)
8.6.2 South Africa
8.6.2.1 COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
8.6.2.2 COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
8.6.2.3 COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
8.6.2.4 COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
8.6.3.2 COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
8.6.3.3 COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
8.6.3.4 COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
Chapter 9 COVID-19 Diagnostics Market: Competitive Landscape
9.1 Company/Competition Categorization (Key Innovators, Market leaders, Emerging Players)
9.2 Recent Developments & Impact Analysis, by Key Market Participants
9.3 Strategy Framework
9.4 Market Participation Categorization
9.5 Company Profiles
9.5.1 Thermo Fisher Scientific Inc.
9.5.1.1 Company overview
9.5.1.2 Financial performance
9.5.1.3 Product benchmarking
9.5.1.4 Strategic initiatives
9.5.2 F. Hoffman-La Roche Ltd.
9.5.2.1 Company overview
9.5.2.2 Financial performance
9.5.2.3 Product benchmarking
9.5.2.4 Strategic initiatives
9.5.3 Perkin Elmer, Inc.
9.5.3.1 Company overview
9.5.3.2 Financial performance
9.5.3.3 Product benchmarking
9.5.3.4 Strategic initiatives
9.5.4 Neuberg Diagnostics
9.5.4.1 Company overview
9.5.4.2 Financial performance
9.5.4.3 Product benchmarking
9.5.4.4 Strategic initiatives
9.5.5 1drop Inc.
9.5.5.1 Company overview
9.5.5.2 Financial performance
9.5.5.3 Product benchmarking
9.5.5.4 Strategic initiatives
9.5.6 Veredus Laboratories
9.5.6.1 Company overview
9.5.6.2 Financial performance
9.5.6.3 Product benchmarking
9.5.6.4 Strategic initiatives
9.5.7 ADT Biotech Sdn Bhd
9.5.7.1 Company overview
9.5.7.2 Financial performance
9.5.7.3 Product benchmarking
9.5.7.4 Strategic initiatives
9.5.8 Altona Diagnostics GmBH
9.5.8.1 Company overview
9.5.8.2 Financial performance
9.5.8.3 Product benchmarking
9.5.8.4 Strategic initiatives
9.5.9 biomérieux SA
9.5.9.1 Company overview
9.5.9.2 Financial performance
9.5.9.3 Product benchmarking
9.5.9.4 Strategic initiatives
9.5.10 Danaher
9.5.10.1 Company overview
9.5.10.2 Financial performance
9.5.10.3 Product benchmarking
9.5.10.4 Strategic initiatives
9.5.11 Mylab Discovery Solutions Pvt Ltd.
9.5.11.1 Company overview
9.5.11.2 Financial performance
9.5.11.3 Product benchmarking
9.5.11.4 Strategic initiatives
9.5.12 Aldatu Biosciences
9.5.12.1 Company overview
9.5.12.2 Financial performance
9.5.12.3 Product benchmarking
9.5.12.4 Strategic initiatives
9.5.13 Quidel Corporation
9.5.13.1 Company overview
9.5.13.2 Financial performance
9.5.13.3 Product benchmarking
9.5.13.4 Strategic initiatives
9.5.14 Quest Diagnostics
9.5.14.1 Company overview
9.5.14.2 Financial performance
9.5.14.3 Product benchmarking
9.5.14.4 Strategic initiatives
9.5.15 Hologic Inc.
9.5.15.1 Company overview
9.5.15.2 Financial performance
9.5.15.3 Product benchmarking
9.5.15.4 Strategic initiatives
9.5.16 Laboratory Corporation of America Holdings
9.5.16.1 Company overview
9.5.16.2 Financial performance
9.5.16.3 Product benchmarking
9.5.16.4 Strategic initiatives
9.5.17 Luminex Corporation
9.5.17.1 Company overview
9.5.17.2 Financial performance
9.5.17.3 Product benchmarking
9.5.17.4 Strategic initiatives
9.5.18 Cepheid
9.5.18.1 Company overview
9.5.18.2 Financial performance
9.5.18.3 Product benchmarking
9.5.18.4 Strategic initiatives
9.5.19 Abbott
9.5.19.1 Company overview
9.5.19.2 Financial performance
9.5.19.3 Product benchmarking
9.5.19.4 Strategic initiatives

List of Tables

TABLE 1 List of secondary sources
TABLE 2 Incidence rate of COVID-19 in North America
TABLE 3 Incidence rate of COVID-19 in Europe
TABLE 4 Incidence rate of COVID-19 in Asia Pacific
TABLE 5 Incidence rate of COVID-19 in Latin America
TABLE 6 Incidence rate of COVID-19 in Middle East and Africa
TABLE 7 Specimen collection and storage for COVID-19 testing
TABLE 8 Different COVID-19 diagnostic tests based on different technologies
TABLE 9 North America COVID-19 diagnostics market estimates and forecasts, by product, 2020 - 2027 (USD Million)
TABLE 10 North America COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 11 North America COVID-19 diagnostics market estimates and forecasts, by technology, 2020 - 2027 (USD Million)
TABLE 12 North America COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 13 U.S. COVID-19 diagnostics market estimates and forecasts, by product, 2020 - 2027 (USD Million)
TABLE 14 U.S. COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 15 U.S. COVID-19 diagnostics market estimates and forecasts, by technology, 2020 - 2027 (USD Million)
TABLE 16 U.S. COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 17 Canada COVID-19 diagnostics market estimates and forecasts, by product, 2020 - 2027 (USD Million)
TABLE 18 Canada COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 19 Canada COVID-19 diagnostics market estimates and forecasts, by technology, 2020 - 2027 (USD Million)
TABLE 20 Canada COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 21 Europe COVID-19 diagnostics market estimates and forecasts, by product, 2020 - 2027 (USD Million)
TABLE 22 Europe COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 23 Europe COVID-19 diagnostics market estimates and forecasts, by technology, 2020 - 2027 (USD Million)
TABLE 24 Europe COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 25 Germany COVID-19 diagnostics market estimates and forecasts, by product, 2020 - 2027 (USD Million)
TABLE 26 Germany COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 27 Germany COVID-19 diagnostics market estimates and forecasts, by technology, 2020 - 2027 (USD Million)
TABLE 28 Germany COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 29 U.K. COVID-19 diagnostics market estimates and forecasts, by product, 2020 - 2027 (USD Million)
TABLE 30 U.K. COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 31 U.K. COVID-19 diagnostics market estimates and forecasts, by technology, 2020 - 2027 (USD Million)
TABLE 32 U.K. COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 33 France COVID-19 diagnostics market estimates and forecasts, by product, 2020 - 2027 (USD Million)
TABLE 34 France COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 35 France COVID-19 diagnostics market estimates and forecasts, by technology, 2020 - 2027 (USD Million)
TABLE 36 France COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 37 Italy COVID-19 diagnostics market estimates and forecasts, by product, 2020 - 2027 (USD Million)
TABLE 38 Italy COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 39 Italy COVID-19 diagnostics market estimates and forecasts, by technology, 2020 - 2027 (USD Million)
TABLE 40 Italy COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 41 Spain COVID-19 diagnostics market estimates and forecasts, by product, 2020 - 2027 (USD Million)
TABLE 42 Spain COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 43 Spain COVID-19 diagnostics market estimates and forecasts, by technology, 2020 - 2027 (USD Million)
TABLE 44 Spain COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 45 Asia Pacific COVID-19 diagnostics market estimates and forecasts, by product, 2020 - 2027 (USD Million)
TABLE 46 Asia Pacific COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 47 Asia Pacific COVID-19 diagnostics market estimates and forecasts, by technology, 2020 - 2027 (USD Million)
TABLE 48 Asia Pacific COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 49 China COVID-19 diagnostics market estimates and forecasts, by product, 2020 - 2027 (USD Million)
TABLE 50 China COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 51 China COVID-19 diagnostics market estimates and forecasts, by technology, 2020 - 2027 (USD Million)
TABLE 52 China COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 53 India COVID-19 diagnostics market estimates and forecasts, by product, 2020 - 2027 (USD Million)
TABLE 54 India COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 55 India COVID-19 diagnostics market estimates and forecasts, by technology, 2020 - 2027 (USD Million)
TABLE 56 India COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 57 Japan COVID-19 diagnostics market estimates and forecasts, by product, 2020 - 2027 (USD Million)
TABLE 58 Japan COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 59 Japan COVID-19 diagnostics market estimates and forecasts, by technology, 2020 - 2027 (USD Million)
TABLE 60 Japan COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 61 South Africa COVID-19 diagnostics market estimates and forecasts, by product, 2020 - 2027 (USD Million)
TABLE 62 South Africa COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 63 South Africa COVID-19 diagnostics market estimates and forecasts, by technology, 2020 - 2027 (USD Million)
TABLE 64 South Africa COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 65 Australia COVID-19 diagnostics market estimates and forecasts, by product, 2020 - 2027 (USD Million)
TABLE 66 Australia COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 67 Australia COVID-19 diagnostics market estimates and forecasts, by technology, 2020 - 2027 (USD Million)
TABLE 68 Australia COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 69 Latin America COVID-19 diagnostics market estimates and forecasts, by product, 2020 - 2027 (USD Million)
TABLE 70 Latin America COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 71 Latin America COVID-19 diagnostics market estimates and forecasts, by technology, 2020 - 2027 (USD Million)
TABLE 72 Latin America COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 73 Brazil COVID-19 diagnostics market estimates and forecasts, by product, 2020 - 2027 (USD Million)
TABLE 74 Brazil COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 75 Brazil COVID-19 diagnostics market estimates and forecasts, by technology, 2020 - 2027 (USD Million)
TABLE 76 Brazil COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 77 Mexico COVID-19 diagnostics market estimates and forecasts, by product, 2020 - 2027 (USD Million)
TABLE 78 Mexico COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 79 Mexico COVID-19 diagnostics market estimates and forecasts, by technology, 2020 - 2027 (USD Million)
TABLE 80 Mexico COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 81 MEA COVID-19 diagnostics market estimates and forecasts, by product, 2020 - 2027 (USD Million)
TABLE 82 MEA COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 83 MEA COVID-19 diagnostics market estimates and forecasts, by technology, 2020 - 2027 (USD Million)
TABLE 84 MEA COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 85 South Africa COVID-19 diagnostics market estimates and forecasts, by product, 2020 - 2027 (USD Million)
TABLE 86 South Africa COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 87 South Africa COVID-19 diagnostics market estimates and forecasts, by technology, 2020 - 2027 (USD Million)
TABLE 88 South Africa COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 89 Saudi Arabia COVID-19 diagnostics market estimates and forecasts, by product, 2020 - 2027 (USD Million)
TABLE 90 Saudi Arabia COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 91 Saudi Arabia COVID-19 diagnostics market estimates and forecasts, by technology, 2020 - 2027 (USD Million)
TABLE 92 Saudi Arabia COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[新型コロナウイルス感染症診断の世界市場2020-2027:製品別、サンプルタイプ別、技術別、最終用途別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆